Liver cell carcinoma Clinical Trials

56 clinical trials for Liver cell carcinoma across international registries, including 21 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells — RECRUITING · PHASE1
• Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma — RECRUITING · PHASE2
• MR-guided brachytherapy for ablation of small liver tumors to optimize dose application — RECRUITING
• Prognostic value of imaging biomarkers in patients with hepatocellular carcinoma treated with liver Transplantation — RECRUITING
• The effects of implementing virtual reality headsets during transarterial treatment of malignant liver tumors — RECRUITING
• Analgesia with fentanyl and midazolam during interventional radiologic liver tumor ablation by catheter-based radiotherapy-safety and risk factors. — RECRUITING
• MR- versus CT-guided biopsy of liver lesions <2 cm to optimize hit rate. - MR. CORRECT trial — RECRUITING
• Assessment of therapeutic success after interstitial brachytherapy of hepatocellular carcinoma using the LI-RADS-TRA algorithm — RECRUITING
• Utilizing Discarded Livers from Donors with a History of Cancer for Patients Lacking Access to Standard Allocation: A Compassionate Use Exploratory Study — RECRUITING
• Prospective, multicenter registry trial to evaluate the efficacy of immunotherapy in patients with advanced hepatocellular carcinoma (HCC) — RECRUITING
• Individualised Liverresection Planning using 3D printing and Virtual Reality — RECRUITING
• Intraoperative measurement of hepatic rigidity — RECRUITING
• Circulating tumor cells to predict survival and monitor treatment response in patients with advanced HCC — RECRUITING
• High-intensity focused ultrasound (HIFU) for local ablative therapy of solid tumors — RECRUITING
• Evaluation of organ and tumour perfusion by contrast-enhanced ultrasound after transarterial chemoembolization because hepatocellular carcinoma — RECRUITING
• Immunemonitoring of patients scheduled for liver transplantation and resection — RECRUITING
• Randomized controlled trial on Pringle Maneuver to reduce blood loss during Stapler Hepatectomy - PriMal StHep — RECRUITING
• Brachytherapy induced volumetric changes of the left liver lobe after interstitial high dose rate brachytherapy of the right liver lobe (BRAVO) — RECRUITING
• HEpatocellular carcinoma stereotactic RAdiotherapy CLinical Evaluation Study — RECRUITING
• A virtual reality environment using a head-mounted display for interactive and immersive 3D operation planning and training for complex liver cases: Is it better than traditional methods? – study protocol for a randomized controlled trail — RECRUITING
• Value of a preoperative volume/ function analysis for patient safety after extended partial liver resection — RECRUITING
• SWARM_Systemic release of growth factors after radioembolization of hepatic malignancies — OTHER
• Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors — COMPLETED · PHASE2
• Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC — NOT_YET_RECRUITING · PHASE2
• Usability of a 29mRNA neuronal network for the prediction of infections in patients following liver transplantation — OTHER
• Evaluation of prognostic factors in long-term survival in patients with hepatocelluar carcinoma (HCC) — OTHER
• AFP - L3% and DCP as tumor markers in patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolisation (TACE) — OTHER
• Selective Intraarterial Radiotherapy (SIRT) with QuiremSpheres: Evaluation of renal and intestinal radioactivity excretion after the Holmium Scout Dose for therapy planning and after SIRT procedures – Aspects of radiation protection and safety — OTHER
• Prospective, multicenter, comparative study of recurrence-free survival after liver transplantation in two tumor stage-defined groups (UNOS T2 versus Milan-out / UCSF-in) of patients with hepatocellular carcinoma (HCC) in cirrhosis and locoregional therapy for bridging the waiting period — OTHER
• Prospective evaluation of image and molecular fingerprint characterization to guide treatment with tyrosine kinase inhibitors in hepatocellular carcinoma — OTHER
• Enlargement of the distance between tumor and adjacent normal tissue/organs (Organs at risk=OAR) by interventional insertion of balloon catheters RAD317 — OTHER
• Mycotic findings in patients after liver transplantation – Invasive mycosis or harmless colonization? — OTHER
• AFP – L3% and DCP as screening marker for a hepatocellular carcinoma in patients with cirrhosis of the liver — OTHER
• Comparison of selenium levels in HCV- infected patients at different stages of disease — OTHER
• Intermittent treatment with sorafenib in combination with transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): a randomized open-label phase 2 study — OTHER
• A Proof-of-concept Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of 4SC-201 and the Treatment Combination of Sorafenib Plus 4SC-201 in Patients With Hepatocellular Carcinoma Exhibiting Progressive Disease Under Sorafenib Treatment. — OTHER
• Incidence and risk factors of viral infections in patients after liver transplantation — OTHER
• Evaluation of liver controller models in liver surgery. — OTHER
• Evaluation of the placement of digital image data in liver- and pancreas surgery — NOT_YET_RECRUITING
• Microvascular invasion of hepatocellular carcinoma predicts microvascular invasion of its recurrence. A potential implication for salvage liver transplantation — OTHER
• TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma — TERMINATED · NA
• Repeat vs single shot antibiotic prophylaxis in major abdominal surgery – prospective observational study — NOT_YET_RECRUITING
• Everyday-based general and visceral surgical case volume, outcome and quality assurance ("real world data") in the elective and emergency setting of a university clinic in a consecutive patient cohort with regard to the season and the influence of the CoVID-19 pandemic — OTHER
• FeasiBIlity and efficacy of tRimodal supporting therapy During ImmunothErapy. Randomized, controlled, pilot trial — NOT_YET_RECRUITING
• Choices of therapeutic strategies for hepatocellular carcinoma (HCC) — NOT_YET_RECRUITING
• A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma — TERMINATED · PHASE3
• Pre- and intraoperative Evaluation of enhanced digital imaging technologies in liver surgery — NOT_YET_RECRUITING
• HepATocellular Cancer Hcv Therapy Study — WITHDRAWN · PHASE3

Refine this search